Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Evolved Machines Enters Into License Agreement with Nanosys and Launches Development of DNA-activated Carbon Nanotube Transistor Sensors

Abstract:
Evolved Machines, Inc. and Nanosys Inc. today announced that Evolved Machines has entered into a sublicense agreement with Nanosys for a portfolio of patents and patent applications related to the use of nanotubes and nanowires for artificial olfaction and chemical sensing.

Evolved Machines Enters Into License Agreement with Nanosys and Launches Development of DNA-activated Carbon Nanotube Transistor Sensors

PALO ALTO, CA | Posted on December 3rd, 2008

The core intellectual property involves a wide range of applications in nanotechnology, nanomaterials and the use of nanotube and nanowire-based field effect transistors (FET's) as biosensors. Nanosys owns an extensive portfolio of IP around multiple aspects of nanotechnology including basic nanowire compositions, nanowire synthesis and the use of nanowires and other nanostructures for many applications.

Under terms of the agreement, Evolved Machines has secured or has obtained options to secure a variety of exclusive, worldwide rights among which are the use of DNA-functionalized nanowire or nanotube-based sensor arrays for the detection and/or identification of an analyte or analytes in the gas and/or liquid phase.

Evolved Machines, in partnership with its affiliate iSense, LLC, is developing nanotube-based field effect transistors (FETS) functionalized by DNA as highly sensitive sensors across a very wide range of targets. "The DNA sequence-dependent nature of binding affinity for these devices enables highly diverse analyte discrimination, while the nanotube transistor imparts great sensitivity. Further, this class of sensor is completely reversible across a wide range of analytes, allowing repeated use and enabling the first devices capable of remote autonomous multi-analyte sensing," according to Dr. Paul A. Rhodes, Evolved Machines CEO.

Working in partnership with its affiliate, iSense, Evolved Machines is developing a wide range of immediate high-value applications ranging from airport, port and transit screening, to first responder domestic and military hand-held sets, to medical diagnosis, to autonomous 24/7 monitoring of the water supply and of containers on-board ship.

####

About Evolved Machines, Inc.
Evolved Machines, Inc. develops technology for sensory systems based on highly neural sensory signal processing, reverse-engineering circuitry in the brain to enable a new class of self-wiring devices that perform in the complexities of real-world environments, for both artificial olfaction and visual object recognition.

About Nanosys, Inc.

Nanosys, Inc. is a leader in the development of nanotechnology enabled products utilizing high performance inorganic nanostructures. Nanosys has built one of the broadest technology platforms in the industry with over 600 patents and patent applications covering fundamental areas of nanotechnology. Based in Palo Alto, California and privately held, Nanosys collaborates with industry leaders to develop revolutionary high-value, high-performance products for life sciences, computing, optoelectronics, renewable energy, and defense.

Additional information on Nanosys can be found at www.nanosysinc.com.

About iSense, LLC

iSense, LLC manufactures broad spectrum chemical sensing devices enabling rapid identification across thousands of analytes. These devices incorporate Evolved Machines' intelligent neural pattern recognitions algorithms to enable performance under real-world conditions. Additional information on iSense can be found at www.isensesytems.com.

For more information, please click here

Copyright © PR Newswire Association LLC.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Materials for the next generation of electronics and photovoltaics: MacArthur Fellow develops new uses for carbon nanotubes October 21st, 2014

Special UO microscope captures defects in nanotubes: University of Oregon chemists provide a detailed view of traps that disrupt energy flow, possibly pointing toward improved charge-carrying devices October 21st, 2014

Super stable garnet ceramics may be ideal for high-energy lithium batteries October 21st, 2014

Could I squeeze by you? Ames Laboratory scientists model molecular movement within narrow channels of mesoporous nanoparticles October 21st, 2014

Sensors

Imaging electric charge propagating along microbial nanowires October 20th, 2014

Graphenea opens US branch October 16th, 2014

IRLYNX and CEA-Leti to Streamline New CMOS-based Infrared Sensing Modules Dedicated to Human-activities Characterization October 15th, 2014

Nanodevices for clinical diagnostic with potential for the international market: The development is based on optical principles and provides precision and allows saving vital time for the patient October 15th, 2014

Announcements

Special UO microscope captures defects in nanotubes: University of Oregon chemists provide a detailed view of traps that disrupt energy flow, possibly pointing toward improved charge-carrying devices October 21st, 2014

Super stable garnet ceramics may be ideal for high-energy lithium batteries October 21st, 2014

Could I squeeze by you? Ames Laboratory scientists model molecular movement within narrow channels of mesoporous nanoparticles October 21st, 2014

Detecting Cancer Earlier is Goal of Rutgers-Developed Medical Imaging Technology: Rare earth nanocrystals and infrared light can reveal small cancerous tumors and cardiovascular lesions October 21st, 2014

Patents/IP/Tech Transfer/Licensing

Nanodevices for clinical diagnostic with potential for the international market: The development is based on optical principles and provides precision and allows saving vital time for the patient October 15th, 2014

Aculon Receives Patent for Application of Enhanced Bonding Layers on Titanium October 9th, 2014

harmaEngine will join Nanobiotix’ pivotal trial for NBTXR3 in Soft Tissue Sarcoma to accelerate its development in Asia-Pacific: PharmaEngine to make milestone payment to Nanobiotix in October 2014 to recognize the value created October 8th, 2014

‘Small’ transformation yields big changes September 16th, 2014

NanoNews-Digest
The latest news from around the world, FREE





  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE